IL231809B - Methods for the treatment of sensory-motor disorder related to stroke using aminopyridines - Google Patents

Methods for the treatment of sensory-motor disorder related to stroke using aminopyridines

Info

Publication number
IL231809B
IL231809B IL231809A IL23180914A IL231809B IL 231809 B IL231809 B IL 231809B IL 231809 A IL231809 A IL 231809A IL 23180914 A IL23180914 A IL 23180914A IL 231809 B IL231809 B IL 231809B
Authority
IL
Israel
Prior art keywords
aminopyridines
stroke
treating
methods
sensorimotor impairment
Prior art date
Application number
IL231809A
Other languages
English (en)
Hebrew (he)
Other versions
IL231809A0 (en
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of IL231809A0 publication Critical patent/IL231809A0/en
Publication of IL231809B publication Critical patent/IL231809B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL231809A 2011-10-04 2014-03-30 Methods for the treatment of sensory-motor disorder related to stroke using aminopyridines IL231809B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161543150P 2011-10-04 2011-10-04
US201261591833P 2012-01-27 2012-01-27
US201261648695P 2012-05-18 2012-05-18
PCT/US2012/058607 WO2013052575A1 (en) 2011-10-04 2012-10-04 Methods for treating a stroke-related sensorimotor impairment using aminopyridines

Publications (2)

Publication Number Publication Date
IL231809A0 IL231809A0 (en) 2014-05-28
IL231809B true IL231809B (en) 2019-06-30

Family

ID=47143280

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231809A IL231809B (en) 2011-10-04 2014-03-30 Methods for the treatment of sensory-motor disorder related to stroke using aminopyridines

Country Status (22)

Country Link
US (2) US20130085167A1 (enExample)
EP (1) EP2766017B1 (enExample)
JP (1) JP6134722B2 (enExample)
KR (1) KR20140084120A (enExample)
CN (2) CN104220072B (enExample)
AR (1) AR088764A1 (enExample)
AU (2) AU2012318719B2 (enExample)
BR (1) BR112014008082A8 (enExample)
CA (1) CA2850635A1 (enExample)
CL (1) CL2014000799A1 (enExample)
CO (1) CO7061067A2 (enExample)
CR (1) CR20140153A (enExample)
EA (1) EA029558B1 (enExample)
HK (1) HK1201204A1 (enExample)
IL (1) IL231809B (enExample)
MX (1) MX354667B (enExample)
PH (1) PH12014500739B1 (enExample)
SG (2) SG11201401248YA (enExample)
TW (1) TWI592156B (enExample)
UA (1) UA114486C2 (enExample)
WO (1) WO2013052575A1 (enExample)
ZA (1) ZA201402432B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2909527A1 (en) * 2013-04-15 2014-10-23 Acorda Therapeutics, Inc. Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines
US10172842B2 (en) 2015-09-11 2019-01-08 PharmaDax Inc. Sustained release oral dosage form containing dalfampridine
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
CN109172573B (zh) * 2018-09-12 2021-01-26 黑龙江中桂制药有限公司 一种口服抗血栓药物及其用途
CN115018836A (zh) * 2022-08-08 2022-09-06 四川大学 一种癫痫病灶自动分割与预测方法、系统及设备

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 4−アミノピリジン誘導体及びその酸付加塩
WO1989009600A1 (en) 1988-04-08 1989-10-19 Massachusetts Institute Of Technology Method and composition for treating neurological disorders
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
CA2085785C (en) * 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition
US5952357A (en) 1993-12-23 1999-09-14 Cornell Research Foundation, Inc. Treating diseases of the anterior horn cells
EP1152760B1 (en) * 1999-02-09 2007-03-28 UAB Research Foundation Use of 4-amino pyridine for treatment of peripheral neuropathies
FR2791571B1 (fr) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
CA2403555A1 (en) * 2000-03-28 2001-10-04 Queen's University At Kingston Methods for effecting neuroprotection
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
EP2667869A1 (en) * 2011-01-28 2013-12-04 Acorda Therapeutics, Inc. Use of potassium channel blockers to treat cerebral palsy

Also Published As

Publication number Publication date
JP6134722B2 (ja) 2017-05-24
AU2012318719A1 (en) 2014-04-17
SG11201401248YA (en) 2014-05-29
US20130085167A1 (en) 2013-04-04
EA029558B1 (ru) 2018-04-30
CR20140153A (es) 2014-07-04
KR20140084120A (ko) 2014-07-04
IL231809A0 (en) 2014-05-28
CN104220072B (zh) 2018-04-17
NZ623255A (en) 2016-08-26
UA114486C2 (uk) 2017-06-26
SG10201600410SA (en) 2016-02-26
PH12014500739A1 (en) 2014-05-26
MX354667B (es) 2018-03-15
TW201321000A (zh) 2013-06-01
ZA201402432B (en) 2020-08-26
AU2012318719B2 (en) 2017-10-19
TWI592156B (zh) 2017-07-21
PH12014500739B1 (en) 2019-05-10
US20160067232A1 (en) 2016-03-10
WO2013052575A1 (en) 2013-04-11
BR112014008082A8 (pt) 2018-01-16
EP2766017A1 (en) 2014-08-20
CA2850635A1 (en) 2013-04-11
AU2018200114A1 (en) 2018-01-25
EP2766017B1 (en) 2020-07-01
HK1204965A1 (en) 2015-12-11
CL2014000799A1 (es) 2014-11-03
CO7061067A2 (es) 2014-09-19
BR112014008082A2 (pt) 2017-07-18
CN104220072A (zh) 2014-12-17
JP2014531470A (ja) 2014-11-27
EA201490562A1 (ru) 2014-08-29
MX2014003997A (es) 2014-07-22
HK1201204A1 (en) 2015-08-28
AR088764A1 (es) 2014-07-02
CN108451953A (zh) 2018-08-28

Similar Documents

Publication Publication Date Title
EP2689416A4 (en) COMMUNICATION APPARATUS
HUE052884T2 (hu) Eljárás intra-predikció végrehajtására adaptív szûrõ használatával
IL233099A0 (en) A method for improved transformation using agrobacterium
GB201111595D0 (en) Improved process
GB201103499D0 (en) Process
GB201107072D0 (en) Process
ZA201208219B (en) Method for treating wasterwater
GB201119960D0 (en) Process
GB201101370D0 (en) Process
EP2670712A4 (en) TREATMENT PROCEDURE FOR THE RECOVERY OF BOR
GB201121557D0 (en) Process
ZA201402432B (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines
GB201107073D0 (en) Process
GB2488097B (en) Printing process
EP2705248A4 (en) ENERGY RECOVERY ARRANGEMENT
GB201119962D0 (en) Process
GB2490171B (en) Recovery method
GB201402836D0 (en) Recovery valve
GB201107221D0 (en) Process
GB201103092D0 (en) Process
SG11201403684YA (en) Process
IL211020A0 (en) A method for treating a lignin stream
GB2493491B (en) Process
PH32011000767S1 (en) A lighter
GB201105395D0 (en) A method

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed